continued from cover... PD protectors and remove without the need for additional adhesives to maintain the extension line. It also fixes the catheter tightly in the pre-cut catheter slot.” In a prospective open study on 22 patients, CATHcarry (pictured right) was described as easy to apply and remove. The opportunity to shower with CATHcarry was also established as a clinical and qualitative advantage. Also the majority of the study population expressed that they will continue with CATHcarry when commercially available1. Contact Rob Fisher 01480 444000 rob.fisher@gambro.com 1. Grandjean J. et al. CATHcarry, a new hypoallergenic waterproof exit site care product protects the exit site during showers. P-66. at EuRoPD Helsinki, 2007. The HCO 1100 membrane has undergone extensive global in-vitro and in-vivo trials and is currently undergoing in-vivo trial within the UK. Meanwhile the WRO 300 H (see article, right) was launched in the UK on Valentine’s Day and has met with a very positive response for both in-centre and in-home use. Visitors to the BRS/RA Conference in Glasgow can also get a preview of our new AK96 HD machine. You will hear more about this product ahead of its launch towards the end of this year. Of course, all of these developments are only possible because of the commitment to Gambro DNA from all our employees. So in February we held a UK company conference which gave staff further opportunities to have some input into the programme, continuing our approach of staff involvement in innovation. As you can see, we really are working hard to deliver products and services focused on the needs of clinicians and patients. Watch out for more news over the coming months and visit www.gambroDNA.co.uk for more details about our programme of innovation. And the winners are... Thanks to all of you who took the time to complete the form we included with the last edition of Highlights. The exercise has helped us to update our mailing list and means we are better able to issue relevant news and product information to our customers. We also entered everyone who replied into a draw to win a copy of the interesting and informative 80-page book, ‘A tour through Gambro’s history of haemodialysis’. The ten winners were: • Jane Cotterill, Dialysis Services Manager, Birmingham Children's Hospital. • Barbara Kane, Practice Development Nurse, Guy’s Hospital. • Tim Langman, Equipment Library Technician, St Richard’s Hospital, Chichester. • Jane MacDonald, Lead Nurse, Renal Services, Salford Royal Foundation Trust. • Nicky Moncrieff, Renal Nurse Specialist, Addenbrookes Hospital. • Andy Mosson, Chief Technician, Churchill Hospital. • Dr Vadamalai Vivek, Consultant, Russell's Hall Hospital. • Dr Simon Roe, Consultant Nephrologist, Nottingham City Hospital, Nottingham. • Gillian Wood, Senior Staff Nurse, Ninewells Hospital, Dundee. • Jackie Williams, Access Nurse, Wrexham Maelor Hospital. 2 Patient care high on the agenda for Gambro DNA DNA update In the last issue of Highlights we launched Gambro DNA; the programme that is bringing us extensive new investment in product and service development. Since then, we have already seen evidence of the positive contribution the programme will make to patient care. Gareth Jones Country Manager, UK & Ireland

Events diary Here are some of the renal care and intensive care events coming up. You’ll find a Gambro stand at all of them, so come and say hello if you attend. ERA-EDTA Congress 10-13 May, Stockholm, Sweden The European Renal Association and European Dialysis and Transplant Association will have a busy scientific programme to address the latest advances in basic and clinical research. For further information visit www.eraedta2008.org and see the article on page 8. The BRS/RA Conference 13-16 May, Scottish Exhibition and Conference Centre, Glasgow The British Renal Society and the Renal Association, in association with the Scottish Renal Association, are offering a comprehensive forum to discuss kidney care and research. Visit us at stand 15. For further information visit www.britishrenal.org and see page 8. The Intensive Care Society - Spring Meeting 19-21 May, Manchester Central Conference Centre International and UK experts will deliver a stimulating scientific programme, with parallel sessions addressing issues of interest to a multi-professional audience. For further information visit www.ics.ac/uk British Association of Critical Care Nurses - the 23rd National Conference 15-17 September, York Racecourse This year’s conference, ‘Caring, Competence & Collaboration’, comprises plenary sessions with leading opinion formers and decision makers. For further information visit www.baccnconference.org.uk The 5th International Symposium on Clinical Applications of Serum Free Light Chain Analysis 18-19 September, Assembly Rooms, Bath Gambro is co-sponsoring this event, which has a full scientific programme focusing on a number of recent trials. For more information visit www.biennial2008.org Contact 01480 444006 marketing.uk@gambro.com The latest contribution to the dialysis fluid ‘hygienic chain’ 3 The unit is designed for use with a single patient, whether in-centre or at home. When used with our latest monitors, it enables end-to-end heat disinfection of the water unit, the connection loop to the dialysis monitor and the monitor itself. Disinfection includes the part of the monitor found before its own heat clean unit, ensuing that the hygienic chain remains unbroken. All of this is achieved through low flow heat disinfection of the dialysis machine internal tubing. The WRO 300 H is just the latest Gambro product development to address the need for superb hygiene in dialysis fluid. This follows other initiatives such as CleanCart and Ultrafilters, which also reinforced our commitment to maintaining the integrity of the hygienic chain to reduce the risk of inflammatory episodes, anaemia and cardio-vascular complications. Our approach now ensures disinfection of the total loop, especially the ‘no man’s line’ distribution loop between water plant and HD machine. Another contribution to effective disinfection is made by our central water plant heat capabilities. No chemicals are used, eliminating the need of residual test strips and providing one simple procedure. It is also automated so that the activity can be performed during the night, leaving the machine ready to operate in the morning. Contact Brian May 01480 444016 brian.may@gambro.com Nowhere is Gambro DNA better embodied than in our developments in water purification and machine cleanliness to deliver the purest dialysis fluid possible. This is encompassed within our ‘hygienic chain’ concept and our latest development: the WRO 300 H water purification unit, which uses hot water purification to disinfect efficiently without using chemicals. Visit www.gambroDNA.co.uk for more details about our programme of innovation. CATHcarry has been developed following extensive research amoung nurses and patients